首页> 美国卫生研究院文献>Filaria Journal >Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs in veterinary dermatology referral centers in Europe

【2h】

Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs in veterinary dermatology referral centers in Europe

机译：在欧洲的兽医皮肤病转诊中心两种磷曲酸钠制剂（NexGard®和NexGardSpectra®）对狗的全身蠕虫病的治疗效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundA multi-centre field trial was conducted to evaluate the efficacy of afoxolaner based chewables (NexGard® or NexGard Spectra®) for the treatment of generalised demodicosis caused by Demodex canis in dogs under field conditions in France, Italy and Poland.

机译：背景技术进行了一项多中心现场试验，以评估在法国，意大利和波兰的野外条件下，基于afoxolaner的咀嚼剂（NexGard®或NexGardSpectra®）在犬中治疗蠕形螨犬引起的全身蠕虫病的功效。

著录项

期刊名称 Filaria Journal
作者
Wilfried Lebon; Massimo Beccati; Patrick Bourdeau; Thomas Brement; Vincent Bruet; Agnieszka Cekiera; Odile Crosaz; Céline Darmon; Jacques Guillot; Marion Mosca; Didier Pin; Jaroslaw Popiel; Dorota Pomorska Handwerker; Diane Larsen; Eric Tielemans; Frédéric Beugnet; Lénaïg Halos;
展开▼
作者单位

展开▼
年(卷),期 2018(11),-1
年度 2018
页码 506
总页数 10
原文格式 PDF
正文语种
中图分类动物医学（兽医学）;
关键词
Demodex canis Generalised demodicosis Mite Dog NexGard® NexGard Spectra® Afoxolaner Isoxazoline Oral Treatment;

机译：蠕形螨;全身蠕形螨;螨虫;狗;NexGard®;NexGardSpectra®;Afoxolaner;异恶唑啉;口服;治疗;

相似文献

外文文献

1. Efficacy of two formulations of afoxolaner (NexGard? and NexGard Spectra?) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe [J] . Wilfried Lebon, Massimo Beccati, Patrick Bourdeau, Parasites Vectors . 2018,第1期

机译：在欧洲的兽医皮肤病学转诊中心，两种磷曲酸钠制剂（NexGard？和NexGard Spectra？）在治疗狗的全身蠕虫病中的功效
2. Preference in Dogs of Two Oral Endectoparasiticide Formulations: NexGard Spectra&sup&®&/sup& (Afoxolaner and Milbemycin Oxime) and Credelio&sup&®&/sup& Plus (Lotilaner and Milbemycin Oxime) [J] . Nadège Perier, Douglas S. Carithers, William Russel Everett, Open Journal of Veterinary Medicine . 2021,第8期

机译：在两个口腔遗留症的狗的偏好：Nexgard光谱＆amp; sup; ＃174;＆amp; / sup＆amp; （AFOXOLANER和MILBIMYCIN OXIME）和Credelio＆amp; LT; sup; ＃174;＆amp; / sup＆amp; 加（LotiLaner和Milbemycin Oxime）
3. Preference in Dogs of Two Oral Endectoparasiticide Formulations: NexGard Spectra®(Afoxolaner and Milbemycin Oxime) and Credelio®Plus (Lotilaner and Milbemycin Oxime) [J] . Nadège Perier, Douglas S. Carithers, William Russel Everett, 兽医学（英文） . 2021,第008期

机译：两种口腔父母酰亚胺酰亚胺代制剂的狗的偏好：NexgardSpectra®（Afoxolaner和Milbemycin Oxime）和Credelio®Plus（LotiLaner和Milbemycin Oxime）
4. Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany [O] . Verena Hampel, Martin Knaus, Jürgen Schäfer, 2018

机译：用afoxolaner（NexGard®）和afoxolaner加milbemycin肟（NexGardSpectra®）咀嚼片治疗犬can肌：葡萄牙和德国在田间条件下的功效
5. Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra®, Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs [O] . Beugnet Frederic, Crafford Dionne, de Vos Christa, 2016

机译：评估每月口服afoxolaner加milbemycin肟（NexGardSpectra®，Merial）预防实验感染狗的成年Spirocerca lupi设立的功效

Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs in veterinary dermatology referral centers in Europe

摘要

著录项

相似文献

相关主题

期刊订阅